The 3rd Annual American Chemical Society Entrepreneurial Summit · 2015-10-12 · 1 DAY The 3rd...

1DAY

The 3rd AnnualAmerican Chemical SocietyEntrepreneurial Summit

September 17-18, 2015#ACSERCsummit

@ACSERCNational Education Association Auditorium

1201 16th Street, NW, Washington, DC 20036

American Chemical Society 1155 Sixteenth Street, N.W. Washington, D.C. 20036 T [202] 872 4461 F [202] 872 6338 www.acs.org

September 17, 2015

Dear Friends:

Welcome to the 3rd annual ACS ERC Entrepreneurial Summit. This event offers an exciting opportunity to gather and learn more about the interplay between entrepreneurs, investors, policymakers, academia, and large innovators in their efforts to advance exciting new chemistry-based products and services to market.

We are delighted that world renowned scholar and author, Dr. Rita Gunther McGrath, Professor at Columbia Business College, can be with us today to deliver a keynote on discovery-based innovation and maintaining competitive edge. This is followed by an afternoon keynote from ACS’s own Executive Director & CEO, Dr. Thomas J. Connelly, who will provide deeper insight into the challenges entrepreneurs face, and how execution can lead to success.

New for 2015 are corporate spotlights, featuring nine remarkable innovators sharing their technology interests and processes for enabling their success. Today’s combination of innovator spotlights and keynotes promises to deliver exciting new and useful insight to attendees.

Day 2 of the Summit offers some new approaches from ACS. ACS is exploring the opportunity to help chemical start-ups in more meaningful and productive ways. Toward that end, tomorrow’s morning program addresses three specific “pain points”, namely, developing the customer, promoting your best value proposition, and creating meaningful and lasting relationships with investors or partners. We also will hear from ACS’s Divisions and Committees about their latest efforts to assist entrepreneurs through legal, business, and product development perspectives. The Summit’s afternoon program “pivots” again with the presentation of four “pitches” from the ACS Entrepreneurial Resources Center’s best showcase start-ups.

I’m proud to suggest that this year’s Summit provides a wide range of programming that promises to offer something for everyone, whether you are entrepreneur, student, investor, policymaker, academic, intrapreneur, or corporate partner.

I look forward to meeting you, and sharing ways to improve people’s lives through the transforming power of chemistry.

Sincerely,

Diane Grob Schmidt, Ph.D. 2015 President

OFFICE OF THE PRESIDENTDiane Grob Schmidt, Ph.D.

President-Elect, 2014 President, 2015

Immediate Past President, 2016

3

Thursday, September 17

8:30AM Registration & Breakfast

9:20AM Introduction Kenneth J. Polk, Esq., Innovation Counsel, ACS

9:25AM Opening Remarks Diane Grob Schmidt, PhD, President, ACS

9:35AM Keynote Introduction Thomas M. Connelly, Jr., PhD, Executive Director & CEO, ACS

9:40AM MORNING KEYNOTE Rita Gunther McGrath, PhD, Professor, Columbia Business School

10:40AM Break

11:00AM Corporate SpotlightDoug White, MBA, Director of New Business Development, Ventures and Business Development, The Dow Chemical Company

11:20AM Corporate Spotlight Mike Cameron, Program Manager-External Technology, The Sherwin-Williams Company

11:40AM Corporate Spotlight John Homoelle, Director of New Technology & Regulatory Affairs, Michelman

Noon Lunch & Networking hosted by Wiley Rein LLP

1:00PM AFTERNOON KEYNOTE Thomas M. Connelly, Jr., PhD, Executive Director & CEO, ACS

2:00PM Corporate Spotlight Saba Husain, MS, Director of Alliance Management, Open Innovation Drug Discovery, Eli Lilly & Company

2:20PM Corporate Spotlight Wael W. Safi, PharmD, Corporate Functions & Open Innovation Manager, Procter & Gamble

2:40PM Break

3:00PM Corporate Spotlight Stuart Pollard, PhD, Associate Vice President and Principal at Sanofi Sunrise

3:20PM Corporate Spotlight Björn Heinz, PhD, Investment Manager, BASF Venture Capital America Inc.

3:40PM Break

4:00PM Corporate Spotlight Neal Dikeman, Senior Venture Principal of Shell Technology Ventures, Royal Dutch Shell

4:20PM Corporate Spotlight Jay Amarasekera, PhD, Senior Technology Manager, SABIC Ventures

4:40PM Closing Remarks Diane Grob Schmidt, PhD, President, ACS

5:00PM Adjourn

AGENDA DAY 1

National Education Association Auditorium • #ACSERCsummit • @ACSERC

4

ACS 2015 ENTREPRENEURIAL SUMMIT • SEPTEMBER 17-18, 2015

AGENDA DAY 2

Friday, September 18

8:30AM Registration & Breakfast

9:00AM Customer & Market Development Panel

Moderator: Dan Daly, PhD, Director, Alabama Innovation & Mentoring of Entrepreneur CenterPANELISTS:• Michael A. Blaustein, PhD, Managing Director, DuPont Ventures• Anita La Salle, PhD, I-Corps Program Manager, & Division for Computer & Network Systems

Program Director, National Science Foundation• Jack Lesko, PhD, Co-PI, DC I-Corps Regional Node• Christina Pellicane, MBS, Executive Manager, NYC Regional Innovation Node

9:50AM Break

10:00AM Business Value Proposition Development Panel

Moderator: Kenneth J. Polk, Esq., Innovation Counsel, ACSPANELISTS:• Dan Daly, PhD, Director, The Alabama Innovation & Mentoring of Entrepreneur Center• Rick Jordan, JD, Asset Strategist, Schlosberg-Jordan• Mark Vreeke, PhD, Co-Founder, Chemical Angel Network• Phillip C. Badger, CTO & Partner, Renewable Oil International MD LLC

10:50AM Break

11:00AM Investor Relationship & Pitch Development Panel

Moderator: Kenneth J. Polk, Esq., Innovation Counsel, ACSPANELISTS:• Marianne Hudson, Executive Director, Angel Capital Association• Howard Lubert, Area President, Keiretsu Forum Mid-Atlantic• John May, MBA, Managing Partner, New Vantage Group• Lex McCusker, PhD, Director, GW New Venture Competition

11:50AM Lunch & Networking hosted by the New Jersey Innovation Institute

1:00PMACS Divisions & Collaborative Organizations Spotlight

Moderator: Anis Rahman, PhD, Chair-Elect, Small Chemical Business DivisionPANELISTS:• Gianna J. Arnold, JD, MA, MS, ACS Mid Atlantic Regional Meeting• Krista E. Bianco, JD, Chair, Chemistry & the Law Division• Dan Daly, PhD, Past-Chair, Business Development & Management Division• Talitha Hampton-Mayo, MSE, President, National Organization for the Professional

Advancement of Black Chemists & Chemical Engineers• Douglas B. Hausner, PhD, Chair, Younger Chemists Committee

1:50PM Break

2:00PMACS Entrepreneurs Spotlight

Moderator: Kenneth J. Polk, Esq., Innovation Counsel, ACSPANELISTS:• Jamie Bacher, PhD, Founder & CEO , Pareto Biotechnologies• Steven Isaacman, PhD, Founder & CEO, PHD Biosciences• Darcy Prather, MA, President, Kalion, Inc.• Alon Singer, PhD, Founder & CEO, HelixBind, Inc.

2:50PM Closing Remarks Kenneth J. Polk, Esq., Innovation Counsel, ACS

3:00PM Adjourn

5

National Education Association Auditorium • #ACSERCsummit • @ACSERCACS 2015 ENTREPRENEURIAL SUMMIT • SEPTEMBER 17-18, 2015

Morning Keynote

“An Entrepreneurial Mindset is Not Optional”Rita Gunther McGrath, PhD, Professor, Columbia Business School

Rita Gunther McGrath, a Professor at Columbia Business School, is regarded as one of the world’s top experts on strategy and innovation with particular emphasis on developing sound strategy in uncertain and volatile environments. Her ideas are widely used by leading organizations throughout the world, who describe her thinking as sometimes provocative, but unfailingly stimulating. She fosters a fresh approach to strategy amongst those with whom she works.

Rita joined the faculty of Columbia Business School in 1993. Prior to life in academia, she was an IT director, worked in the political arena, and founded two startups. She received her Ph.D. from the Wharton School, University of Pennsylvania and has degrees with honors from Barnard College and the Columbia School of International and Public Affairs. She is married and is proud to be the mother of two delightful grownups.

Afternoon Keynote

“Core Concepts for Successful Innovation in Chemistry”Thomas M. Connelly, Jr., PhD, Executive Director & CEO, ACS

Thomas M. Connelly, Jr. is the Executive Director and CEO of the American Chemical Society. Dr. Connelly retired from DuPont in December 2014, where he was Executive Vice President, Chief Innovation Officer. At DuPont, Dr. Connelly led businesses and R&D organizations, while based in the U.S., Europe, and Asia.

Dr. Connelly graduated with highest honors from Princeton University with degrees in Chemical Engineering and Economics. As a Winston Churchill Scholar, he received his Doctorate in Chemical Engineering from the University of Cambridge. He has served in advisory roles to the U.S. Government and the Republic of Singapore.

6

ACS 2015 ENTREPRENEURIAL SUMMIT • THURSDAY, SEPTEMBER 171DAY

DAY ONE

Opening Remarks

Diane Grob Schmidt, PhD, 2015 President, ACS

Dr. Diane Grob Schmidt is the President of the American Chemical Society. She holds a Ph.D. in Organic Chemistry from the University of Cincinnati. She received a M.S. from the University of Tennessee, and a B. A. in chemistry from the University of Tennessee—Chattanooga. Immediately after finishing her Ph.D., she joined the Procter & Gamble Company (P&G), where she served as Section Head with responsibility for safety and regulatory affairs before retiring earlier this year. She is an Adjunct Professor of Chemistry at the University of Cincinnati. Diane’s research interests include carbohydrate chemistry, heterocyclic chemistry, polymers, separations technology, controlled release/delivery systems and chemistry as applied to consumer products. At P&G she developed and evaluated technologies for a variety of consumer products, and became a Certified Chemical Hygiene Officer. She holds multiple U. S. patents and corresponding applications and filings internationally. She has authored scientific publications and technical presentations.

Corporate Spotlights

Doug White, MBA, Director of New Business Development, Ventures and Business Development, The Dow Chemical Company

Mr. Doug White is a senior director of new business development in Corporate Venturing for The Dow Chemical Company. He is responsible for directing the portfolio of early stage ventures derived from both internal and external opportunity sources with a focus on technology scouting and collaborative models for efficient early opportunity screening and engagement. Dow Corporate Venturing practices a variety of open innovation models within its portfolio including joint development agreements, licenses, strategic alliances/joint ventures, and equity investments. Doug’s 29-year Dow career spans several areas including product R&D, marketing and business development leadership roles covering the early stage of product inception through commercialization. He has managed and directed new business ventures for Dow in many industries including Automotive/Transportation, Textiles, Polyurethane Products, Advanced Ceramics/Materials, Medical Devices, Defense, Energy, and Water Treatment. Doug earned a Bachelor of Science in Chemical Engineering from Michigan Technological University and an MBA from Rice University.

7

National Education Association Auditorium • #ACSERCsummit • @ACSERC 1DAY

Mike Cameron, Program Manager-External Technology, The Sherwin-Williams Company

Mr. Mike Cameron has spent more than 30 years in the coatings industry with experience in the automotive, industrial and architectural fields, working in solvent and water based systems as well as single and multi-component chemistries. With patents received for a number of coatings technologies, Mr. Cameron has worked in management as well as an individual contributor, with duties ranging from technical service and quality control, to long-term product development. In his current role as Program Manager with the External Technology Group at Sherwin-Williams, Mr. Cameron is charged with securing strategic externally sourced partnerships to accelerate technology, process and product development. He commonly collaborates with universities, small companies, inventors, research institutions, industries parallel to coatings, and non-coatings business units of large companies.

John Homoelle, Director of New Technology & Regulatory Affairs, Michelman

Mr. John Homoelle has been with Michelman for 39 years. In this time he has performed research at the bench, managed all lab staff, overseen ISO certification and TQM practices, oversaw and led the first IT installation at Michelman, has been on the executive leadership team of John Michelman where Michelman’s first Strategic Plan was created, and oversees the regulatory functions of the company. His current role is Director of New Technology and Regulatory Affairs where he has been tasked with changing the culture of Michelman to one that supports innovation regardless of its origin. John is a native of Cincinnati and holds a master’s degree in chemistry from the University of Cincinnati. John is here today to share the journey with you on how Michelman has transformed itself to a company that openly pursues and embraces innovation as the means to meet the needs of its markets and customers.

Saba Husain, MS, Director of Alliance Management, Open Innovation Drug Discovery, Discovery Chemistry, Eli Lilly & Company

Ms. Saba Husain is Director of Alliance Management for Lilly’s Open Innovation Drug Discoveryprogram. Saba manages the OIDD portfolio. She cultivates the relationships with OIDD investigatorsand Lilly Research Labs within the early drug discovery space, and has the leadership role incollaboration negotiations for OIDD. Saba joined Eli Lilly in 1999 and held a variety of roles contributingto lead generation/optimization teams. She also served as a Six Sigma Black Belt from 2008 to 2010.Forthe last several years, Saba served as a member of the OIDD implementation team by establishing the PD2 Screening Program, which was the precursor of today’s OIDD Screening Offering. Saba also held a leadership role in the Lilly/NCATS collaboration focused on the profiling of the NCATS PharmaceuticalCollection, which has been described in a recent publication in PLOS One. Saba has a M.S. degree inPharmaceutical Sciences from Butler University, Indianapolis.

8

ACS 2015 ENTREPRENEURIAL SUMMIT • THURSDAY, SEPTEMBER 171DAY

Wael W. Safi, PharmD, Corporate Functions & Open Innovation Manager, Procter & Gamble

Dr. Wael Safi’s international health and consumer care related experience includes over 11 years in the pharmaceutical and consumer goods industry, in the areas of research, communications, and business development. He currently is an Open Innovation Leader for the Procter & Gamble Company where he leads R&D efforts harvesting the Silicon Valley ecosystem for partnerships and technologies as well as developing and growing partnerships with North American Universities. He has held several advisory roles for local charities and foundations, and currently serves as an advisor to several start-ups, academic institutes, and government organizations.

Katherine Bowdish, PhD, Vice President Global R&D & Head of Sanofi Sunrise, Sanofi US

Dr. Katherine Bowdish joined Sanofi as Vice President of Global R&D, to build and lead Sunrise, an investment and partnering group within Sanofi. Sunrise works with academic founders, the venture capital community, and Sanofi in unique relationships to foster early stage opportunities to accelerate transformative treatments to patients. Prior to joining Sanofi, Katherine spent the last two decades founding, building and leading early stage biotechnology companies with a focus on biological therapies. Katherine most recently led Permeon Biologics as its President & CSO. Prior to taking the helm at Permeon, Katherine co-founded and served as President & CEO of Anaphore. Katherine was President of Alexion Antibody Technologies, Inc. and Senior Vice President, Alexion Pharmaceuticals upon leading the acquisition of Prolifaron where she was the founder, CEO & CSO. Katherine received her Ph.D. from Columbia University College of Physicians and Surgeons and B.S. from the College of William and Mary.

Björn Heinz, PhD, Investment Manager, BASF Venture Capital America Inc.

Dr. Björn Heinz has served his last two years as Investment Manager at BASF Venture Capital America. Prior to his current role, Björn was at BASF as a team leader in the development of metallization pastes and research of performance chemicals. Björn holds a Ph.D. in Biomolecular Optics from the University of Munich. He has filed six international patents and applications, has led and co-authored 13 articles in high-ranked peer reviewed scientific journals, and has spoken at numerous conferences in the venture capital, oilfield, electronic chemicals, and physical chemistry areas.

9

National Education Association Auditorium • #ACSERCsummit • @ACSERC 1DAY

Neal Dikeman, Senior Venture Principal of Shell Technology Ventures, Royal Dutch Shell

Mr. Neal Dikeman is a serial entrepreneur and venture capital investor with experience across energy, power, Cleantech, and IT. He has a long track record of launching new ventures to commercialize technology across nine startups and a number of multinationals on three continents. He is currently a venture capitalist at the corporate venture capital arm of Royal Dutch Shell, as well as currently serves on the boards of American Electric Technologies, Inc. (NASDAQ:AETI) and Greenhome.com. Prior to Shell he was a founding partner at energy tech merchant bank Jane Capital Partners, investing in energy, Cleantech, and IT. While at Jane Capital he helped found six startups and invest in and incubate numerous others, leading to multiple exits including two IPOs. He began his career in the oil & gas investment banking group at Bankers Trust and Deutsche Bank, and holds a B.A. from Texas A&M in Economics.

Jay Amarasekera, PhD, Senior Technology Manager, SABIC Ventures

Dr. Jay Amarasekera is a Senior Technology Manager attached SABIC Ventures, the corporate venture arm of Saudi Basic Industries Corporation which is one of the world’s top petrochemical companies with more than $50B sales. Prior to this role, Jay served as a Technology Manager for Performance Chemicals and Innovative Plastics business units. Before SABIC, he served in many managerial positions in General Electric’s former Plastics and Silicones businesses both in U.S.A. and China. Prior to joining GE, Jay worked as a Research Scientist in BASF Corporation’s Colorant & Coatings and Performance Chemicals divisions. He was also a Research Associate in Michigan State University where his research was focused on clay composites for catalytic applications. Jay holds a Ph.D. in Inorganic Chemistry from University of Illinois at Urbana Champaign, Master of Science in Chemistry from Bowling Green State University in Ohio and Bachelors in Science from University of Peradeniya Sri Lanka. Jay is a certified Six-Sigma Black Belt.

10

DAYACS 2015 ENTREPRENEURIAL SUMMIT • FRIDAY, SEPTEMBER 182

DAY TWO

Customer & Market Development Panel

Moderator: Dan Daly, PhD, Director, Alabama Innovation & Mentoring of Entrepreneur Center

Dr. Dan Daly received B.S. in Chemistry and Psychology from Florida State University and his Ph.D. in Physical-Organic Chemistry from the University of Florida. He did two post-doctoral studies at The University of South Florida and Oregon State University in computer-assisted molecular design. Dr. Daly is currently the Director of the Alabama Innovation and Mentoring of Entrepreneurs Center. He has 17 years of experience in the fuel and lubricant businesses where he served as Technology and Business Development Manager. He has led the development of several commercially successful projects and has managed and coordinated fundamental programs at several universities and national laboratories. Dr. Daly has won several awards for this work including: Nortech Top 50 Industrial Innovation Award for Northeast Ohio; Recipient, R&D Magazine Top 100 Industrial Innovation Awards Recipient; and ACS Environmental Industrial Innovation Award.

PANELISTS:

Michael A. Blaustein, PhD, Managing Director, DuPont Ventures

Dr. Michael Blaustein is Managing Director of DuPont Ventures and Planning Director for Science and Technology at DuPont. Michael began his DuPont career in 1982 as a research chemist in the aramid fibers business. He held technology, marketing, and business leadership positions in DuPont Nonwovens and DuPont Advanced Fibers Systems until becoming Business Director for DuPont Nonwovens in Europe in 1997. In 2001 he became Planning Director for DuPont Central Research and Development. He has worked across DuPont on technology portfolio and innovation management and with external parties on collaborative research and open innovation. Michael holds a B.A. in Chemistry from Columbia University and a Ph.D. in Chemistry from Yale University.

11

National Education Association Auditorium • #ACSERCsummit • @ACSERCDAY

2

Anita La Salle, PhD, I-Corps Program Manager, & Division for Computer & Network Systems Program Director, National Science Foundation

Dr. Anita J. La Salle is Program Director in the National Science Foundation’s Division for Computer and Network Systems (CNS) where she manages the NSF Innovation Corps (I-Corps) Programs. Anita is Professor Emeritus from American University (AU) in Washington, DC where she served as Chair of the Computer and Information Science Department, in the College of Arts and Sciences, and Chair of the Information Technology Department, in the Kogod School of Business. Prior to joining NSF and AU, Anita had a career in industry and was a faculty member at the New Jersey Institute of Technology (NJIT). She earned her B.S. and M.S. degrees in Mechanical Engineering from NJIT and her Ph.D. in Computer Science from Stevens Institute of Technology. Her research interests include Software Engineering and Software Process Improvement, Project Risk Assessment, and Systems Software. She is a member of the IEEE.

Jack Lesko, PhD, Co-PI, DC I-Corps Regional Node

Dr. Jack Lesko is the Associate Dean for Research & Graduate Studies at Virginia Tech and serves as the Co-PI for the DC I-Corps Regional Node. His office provides support to faculty in developing research efforts by helping them to identify possible funding agencies, by coordinating faculty groups for multidisciplinary research proposals, by negotiating cost sharing for proposals when necessary, and by coordinating negotiations for research contracts between the college and outside agencies. He holds a Bachelor of Science in mechanical engineering from the University of Maryland, College Park, a Master of Science degree and a Ph.D. in engineering mechanics from Virginia Polytechnic Institute and State University.

Christina Pellicane, MBS, Executive Manager, NYC Regional Innovation Node

Ms. Christina Pellicane is the Executive Manager of the NYC Regional Innovation Node, funded by the National Science Foundation for $3.74M, as the northeast NSF I-Corps Node led by CUNY in partnership with NYU and Columbia. She also serves as CUNY’s manager of the PowerBridgeNY program, funded by NYSERDA for $10M. She has helped form 20+ I-Corps teams, brought in over $1M of commercialization grants to the region, coached several life science startups, and participated in multiple NSF I-Corps cohorts. She is a national I-Corps teaching team member and a regional instructor at schools and incubators in New York, New Jersey, Pennsylvania, and Connecticut. Previously, Ms. Pellicane worked in business development at a veterinary CRO and as a Research Associate at a biotech startup. Ms. Pellicane holds a B.S. in Biology and Animal Science from the University of Georgia as well as a Master of Business and Science with a concentration in Biotechnology and Genomics from Rutgers University.

12


Business Value Proposition Development Panel

Moderator: Kenneth J. Polk, Esq., Innovation Counsel, ACS

Mr. Ken Polk brings his unique legal, business, and technical knowledge, background, and experience to the ACS Entrepreneurial Resources Center and to the summit event. Having counseled entrepreneurs, raised capital, and held executive positions within early-stage startups over the past twenty years, he is keenly aware of the myriad of challenges that entrepreneurs face in commercializing promising, fledgling chemistry-based technologies and pathways that lead to commercial success. As Innovation Counsel at ACS, Ken uniquely leverages ACS’s core competencies and strengths toward helping its member chemical entrepreneurs succeed.

PANELISTS:

Dan Daly, PhD, Director, The Alabama Innovation & Mentoring of Entrepreneur Center

Refer to Customer & Market Development Panel for bio (on page 10)

Rick Jordan, JD, Asset Strategist, Schlosberg-Jordan

Mr. Richard Jordan is a founding member of Schlosberg-Jordan, a consulting company specialized in reducing investment-risk and increasing company asset value as early-stage technical ideas in the oil, gas, chemicals and materials markets are advanced toward commercialization. Schlosberg-Jordan applies its unique staged evaluation process to reduce investment-risk and increase company asset value by obtaining and analyzing relevant data over a progressive series of staged assessments, focusing on technical feasibility, market (strategic) fit and competitive advantage at every stage. As an asset strategist having the task of implementing strategies for building intellectual property asset value, Rick relies on his over 35 years of actual work experience in diverse professional environments, including former patent counsel at Exxon, patent examiner at the US Patent and Trademark Office, chemical engineer at Placid Refining Company, and marine research technician at the University of Texas Marine Science Institute.

13


2

Mark Vreeke, PhD, Co-Founder, Chemical Angel Network

Dr. Mark Vreeke is a cofounder of the Chemical Angel Network (CaN). CaN brings together entrepreneurs and investors who are working on growing companies with a strong Chemistry component. CaN’s ideal investment is a seed stage deal where the company can benefit from both CaN’s financial and technical resources. Mark’s background is in the medical device and diagnostic space. He was employed by Pepex Biomedical, SpectRx, TheraSense, Bayer, and Hospira where his roles ranged from Research Scientist to Senior VP of R&D. Mark earned a B.S. in Chemistry from Calvin College and a Ph.D. in Analytical Chemistry from the University of Texas at Austin. Academic honors include a Welch Fellow, a Woodrow Wilson Fellow and the accreditation of Professor by the ACQ in Spain.

Phillip C. Badger, CTO & Partner, Renewable Oil International MD LLC

Mr. Phillip Badger is a professional engineer and bio-based entrepreneur with over 35 years’ experience with virtually all aspects of biomass and bioenergy. He is currently the Chief Technology Officer for Renewable Oil International MD, a firm commercializing an innovative thermochemical conversion technology to convert carbon-rich materials into fuels, chemicals, gas, and biochar. He previously led the U.S. Department of Energy’s Southeastern Regional Biomass Energy Program for 15 years, providing companies with information transfer and commercialization assistance and assisting to develop state bioenergy programs. Prior to that he was the leader of the Tennessee Valley Authority’s concentrated acid cellulose-to-ethanol research program.

14


Investor Relationship & Pitch Development Panel


PANELISTS:

Marianne Hudson, Executive Director, Angel Capital Association

Ms. Marianne Hudson leads the Angel Capital Association (ACA), the world’s leading professional and trade association focused on fueling the success of accredited angel investors and portfolio companies in high-growth, early-stage ventures. ACA provides professional development, public policy advocacy and significant benefits and resources to its membership of more than 13,000 individual accredited investors throughout North America. Ms. Hudson led the angel initiative at the Kauffman Foundation and also oversaw many of the Foundation’s entrepreneurial education and mentoring programs designed to ensure that more entrepreneurs develop sustainable, innovative businesses. An angel investor herself, Ms. Hudson is a member of the Women’s Capital Connection and Mid-America Angels in her home base of Kansas City. Ms. Hudson has worked in the entrepreneurial support field for more than 25 years. She holds a B.A. in Economics and Political Science from the University of Kansas and an M.A. in Public Policy from Rutgers University.

Howard Lubert, Managing Director, Rowan Innovation Venture Fund

Mr. Howard Lubert is the Area President for Keiretsu Forum Mid-Atlantic and Keiretsu Forum South-East, the two East Coast regions of the world’s largest angel investment network. He is the Founder and Managing Partner/Senior Analyst at SafeHatch LLC, a business acceleration and corporate advisory services consultancy that supports startup and early stage technology companies. Howard brings 35+ years of formalizing and optimizing the due diligence and deal flow processes for various venture capital funds including Safeguard Scientifics and its family of private equity funds, as well as other angel investment groups to Keiretsu Forum Mid-Atlantic. Mr. Lubert was also senior manager at Deloitte & Touche, where he played a principal role in the development of the e-business consulting practice. Mr. Lubert recently became the Managing Director of the Rowan University Innovation Venture Fund (RIVF), an Evergreen Fund designed to support the entrepreneurial and innovation initiatives on the Rowan University campuses as well as the South Jersey area.

15


2

John May, MBA, Managing Partner, New Vantage Group

Mr. John May is the managing partner of New Vantage Group, a McLean, VA firm that innovatively mobilizes private equity into early-stage companies and provides advisory services to both funds, private investors and entrepreneurs. Mr. May’s experience in private equity capital over the last 25 years ranges from venture capital fund management to angel investing in the U.S.A. and angel ecosystem development abroad. Mr. May has been at the forefront of the angel investor movement. He is the founder of five investment groups, as well as the Investors’ Circle, a national non-profit group of 125 family and institutional investors working to grow the social venture capital industry. Mr. May holds a B.A. from Earlham College, an M.P.A. from the Maxwell School at Syracuse University and is a Batten Fellow at the University of Virginia’s Darden School of Business.

Lex McCusker, PhD, Director, GW New Venture Competition

Dr. Lex McCusker is the Director of the New Venture Competition at George Washington University. Previously, he was Dean of the Business School at Stevens Institute of Technology in Hoboken, NJ. Prior to joining Stevens Institute, Dr. McCusker worked for 23 years at AT&T and Bell Laboratories in software development, professional technology services, technology licensing, and intrapreneurship. He was CEO of the AT&T text-to-speech startup, Natural VoicesTM. He is also an angel investor and member of the Mid-Atlantic chapter of the Keiretsu Forum. Lex holds a doctorate in Experimental Psychology from The University of Texas at Austin and a bachelor’s degree in Psychology from Dartmouth College.

ACS Divisions & Collaborative Organizations Spotlight

Moderator: Anis Rahman, PhD, Chair-Elect, Small Chemical Business Division

Dr. Anis Rahman is Chair-Elect of the Small Chemical Businesses Division. He is the founder and Chief Technology Officer of Applied Research and Photonics Inc., located in Harrisburg, PA. Dr. Rahman is known for his work on Dendrimer based non-linear optics, photonics and terahertz technology. ARP was founded in 2003 to harness the unique capabilities of a nanomaterial called Dendrimer. Coined the term “silicon for photonics”, Dr. Rahman’s approach makes it possible to fabricate chip based components for fiber-optic communication. Dr. Rahman has contributed more than 80 publications and conference presentations and produced 12 patents on terahertz and fiber-optics related topics. With Dr. Rahman’s leadership, Applied Research and Photonics technology and products received prestigious awards including the NASA Nanotech Brief’s nano-50 award and CLEO/Laser Focus World’s Innovation award. Anis Rahman completed his graduate work at Marquette University and a postdoctoral research position at Columbia University.

16


PANELISTS:

Gianna J. Arnold, JD, MA, MS, ACS Mid Atlantic Regional Meeting

Ms. Gianna Arnold is a representative from the ACS Mid Atlantic Regional Meeting and has long been active with the ACS Division of Small Chemical Business. She is vice chair of the Life Sciences practice and a partner in the Intellectual Property & Technology Practice at Saul Ewing LLP. With advanced degrees in science and law and drawing from her experience as a scientist, as an entrepreneur and as a corporate executive, Gianna’s practice is directed to enhancing company value through protecting, leveraging and enforcing intellectual assets and through developing and memorializing strategic alliances. Gianna is licensed before the United States Patent and Trademark Office and represents Fortune 500 corporations, start-up and growth companies, and universities in the development and management of patent, trademark and copyright portfolios, sponsored research, joint development, licensing and product development. She helps clients to identify, protect and manage their intellectual assets and to secure and enforce their intellectual property rights worldwide.

Krista E. Bianco, JD, Chair, Chemistry & the Law Division

Ms. Krista Bianco is an attorney with the Intellectual Property law firm, Finnegan, Henderson, Farabow, Garrett & Dunner LLP, here in Washington DC. Ms. Bianco practices patent litigation before federal district courts and the U.S. International Trade Commission (ITC) involving a wide range of chemical and pharmaceutical technologies, with particular experience in organic molecules. Ms. Bianco also maintains an active patent prosecution practice, preparing and prosecuting U.S. and foreign patent applications on behalf of clients worldwide. She has specific experience drafting patent applications for chemical and pharmaceutical manufacturing processes and prosecuting chemical compound, pharmaceutical composition, and method-of-use applications in the United States and other countries. Ms. Bianco is the current chair of the Chemistry and the Law Division of ACS and has served as program chair for CHAL since 2010.

Dan Daly, PhD, Past-Chair, Business Development & Management Division

Refer to Customer & Market Development Panel for bio (on page 10)

17


2

Talitha Hampton-Mayo, MSE, President, National Organization for the Professional Advancement of Black Chemists & Chemical Engineers (NOBCChE)

Ms. Talitha Hampton-Mayo is currently a project manager and strategy specialist at Merck. She is responsible for performing critical planning, business communications, project execution and strategy coordination in support of the Biologics Commercialization Leadership Team and development, optimization, and support of business and technical systems for the global Biologics Commercialization organization. Talitha serves as the National President of the NOBCChE and has been instrumental in helping the organization to establish its professional development programming, maintain a social networking presence, and develop partnerships with other professional technical organizations. Talitha earned a bachelor’s degree in Chemistry from Oakwood University and a master’s degree in Chemical Engineering from the University of Alabama in Huntsville. She enjoys spending time with her family and husband, singing, mentoring, basketball, boxing, graphic design, and sightseeing. She lives by the motto, “If you are not at the table, then you are on the menu”.

Douglas B. Hausner, PhD, Chair, Younger Chemists Committee

Dr. Doug Hausner is currently the Associate Director for Industrial Relations and Business Development with the Engineering Research Center for Structured Organic Particulate Systems (C-SOPS) based at Rutgers University in New Jersey. C-SOPS is the largest academic/industrial research consortium focused on pharmaceutical applications, involving over 100 academic researchers, and more than 50 industrial partners. Doug attended the University of Delaware as an undergrad and received his Ph.D. from Temple University in Philadelphia. He has been active in the Philadelphia local section since his days in graduate school serving on the board of directors and initiating a YCC chapter. Doug is currently the chair of the National Younger Chemist Committee (YCC).

18


ACS Entrepreneurs Spotlight


PANELISTS:

Jamie Bacher, PhD, Founder & CEO , Pareto Biotechnologies

Having worked in both biofuels and therapeutics, Dr. Jamie Bacher saw the potential for application of underexploited chemistries to familiar problems, and founded Pareto Biotechnologies to utilize them in novel ways. Dr. Bacher has a history of initiating and leading teams to overcome technical challenges. On behalf of Total New Energies in their partnership with Amyris to generate biofuels, he co-led an 80 employee, $100M project as Deputy Program Manager. At Sapphire Energy, he established a technical infrastructure that was critical to Sapphire’s partnership with Monsanto. He similarly led technical efforts at Rincon Pharmaceuticals as the first scientist to focus on whole-cell optimization; efforts which led to a $100 million funding milestone for the company. Dr. Bacher has a B.Sc. from McGill University in Biology, and a Ph.D. from University of Texas at Austin in Molecular Biology. He conducted his post-doctoral research at Maxygen, Inc., and The Scripps Research Institute.

Steven Isaacman, PhD, Founder & CEO, PHD Biosciences

Dr. Steven Isaacman founded PHD Biosciences (formerly Nanometics LLC) in 2008, and is responsible for the design and fabrication of several products that are currently sold globally. Since 2010, he has been the Principal Investigator on awards that total more than $7.1 million including: three SBIR awards from the National Cancer Institute, one STTR award from the National Cancer Institute, two SBIR awards from the National Heart Lung and Blood Institute, a SBIR award from the National Center for Advancing Translational Science, an Avon Foundation award, and three New York State Center for Advanced Technology awards. At PHD Biosciences, he leads the research team; developing novel small-molecules for the oncology and hematology. Dr. Isaacman received his B.S. in Biochemistry and M.S. in Organic Chemistry from Stony Brook University and his Ph.D. in organic chemistry from New York University where his research focused on self-assembling nanoarchitectures for oncology.

19


2

Darcy Prather, MA, President, Kalion, Inc.

Mr. Darcy Prather serves as President of Kalion, Inc. and has spent the last couple of decades developing new businesses from emerging technologies. He received two S.B.’s from the Massachusetts Institute of Technology in Electrical Engineering; and Science, Technology and Society. He received an M.A. in Philosophy, Politics and Economics from Oxford University which he attended on a Rhodes Scholarship. Darcy started his career as a management consultant at McKinsey & Co. spending significant time studying R&D. He advised major agriculture player on potential impact of various intellectual property strategies for seminal biotech product that continues to drive value even today. He developed a new research and development organizational structure for major packaged goods company that was immediately adopted. Darcy has served as VP of Technology for NiaOnline, the largest online community for African Women, and VP of Strategy for Beta Data Services, Inc., a telecommunications billing system company.

Alon Singer, PhD, Founder & CEO, HelixBind, Inc.

Dr. Alon Singer is the CEO of HelixBind and the inventor of its core technology platform. Dr. Singer received his Ph.D. in Biomedical Engineering from Boston University where he developed cutting-edge nanofluidic optoelectronic devices for molecular diagnostics and has authored over 20 peer-reviewed articles, book chapters, and patent applications. Previous to HelixBind, Dr. Singer held a field command position in the Israeli Defense Forces, has led assay development at TissueVision, and has consulted for both emerging and Fortune Global 500 companies in the biotech/med-device space.

20

Summit Sponsors

Kay Tatum [email protected]

wileyrein.com

Wiley Rein has been proud to provide a full range of services to the American Chemical Society for more than 10 years, including:

For more information on how Wiley Rein can help your chemistry-based startup, please contact:

Corporate

Cybersecurity

Employment

Government Ethics

Intellectual Property

International

Tax

New Jersey Innovation Institute

is a proud sponsor of the

2015 ACS Entrepreneurial Summit

September 17-18, 2015

973-596-5800 • [email protected] • www.njii.comNew Jersey Institute of Technology

University Heights • Newark, NJ 07102

ERC Sponsors

ACS 2015 ENTREPRENEURIAL SUMMIT • THURSDAY, SEPTEMBER 17

21


Summit Sponsors

Notes

________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

ERC Sponsors


22


Notes

________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

23


Notes

________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

AUDIOTAPING, PHOTOGRAPHY & VIDEOTAPINGThe use of any device to capture images (e.g., cameras and camera phones) or sound (e.g., tape and digital rebroadcast) of speakers or presentations

is strictly prohibited at all ACS meetings and events without the express written consent from ACS.

The 3rd Annual American Chemical Society Entrepreneurial Summit · 2015-10-12 · 1 DAY The 3rd...

Documents

Transcript of The 3rd Annual American Chemical Society Entrepreneurial Summit · 2015-10-12 · 1 DAY The 3rd...